辰欣药业：股东石四药拟减持不超过1%公司股份

Core Viewpoint - Shareholder Shijiazhuang Four Pharmaceutical Co., Ltd. plans to reduce its stake in Chenxin Pharmaceutical through centralized bidding, citing funding needs as the reason for the reduction [1] Summary by Category Shareholder Actions - Shijiazhuang Four Pharmaceutical Co., Ltd., a shareholder holding more than 5% of the company, intends to reduce its holdings by a maximum of 4,527,000 shares, which represents no more than 1% of the total share capital of the company [1] Reduction Timeline - The reduction period will commence 15 trading days after the announcement and will last for three months [1]